Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed Sep 19, 2025
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-09-18+50,000→ 50,000 totalExercise: $19.23Exp: 2035-09-18→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The option was granted on September 18, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on September 18, 2026.
- [F2]Not applicable.